Adams Kendra — SEC Form 4 filings
SEC reporting owner CIK 1991929. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-15 to 2026-02-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | 8 | — | — | 23 |
Form 4 filings — Adams Kendra
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 240,000 @ $0 · Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,863 @ $1.89 · Option exercise (M): 30,950 @ $0 · Tax withholding (F): 15,381 @ $1.89 | EDGAR |
| 2025-09-19 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 6,250 @ $0 · Tax withholding (F): 2,775 @ $3.32 | EDGAR |
| 2025-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 1,863 @ $3.20 · Grant/award (A): 87,100 @ $0 · Tax withholding (F): 4,559 @ $3.18 · Grant/award (A): 130,600 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 3,750 · Tax withholding (F): 1,102 @ $6.04 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 1,837 @ $6.38 | EDGAR |
| 2024-09-17 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 2,250 · Tax withholding (F): 661 @ $6.36 · Option exercise (M): 2,250 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | C4 Therapeutics, Inc. (CCCC) | Disposition to issuer (D): 45,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 1,301 @ $6.53 · Grant/award (A): 36,700 @ $0 · Grant/award (A): 165,300 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1991929 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →